Lilly to acquire Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk
Investors | Eli Lilly and Company   13 hours ago
ads
Read Full Story
Lilly to acquire Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk  Eli Lilly and CompanyEli Lilly to Acquire Verve Therapeutics for Up to $1.3 Billion  WSJEli Lilly strikes deal to buy Crispr gene-editing...